Abstract:Jinhui Cui, &ast Ping Li, &ast Xinjuan Chen, Ling Li, Liping Ouyang, Zhaoran Meng, Jianhui Fan Department of Obstetrics and Gynecology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianhui Fan, No. 600, Tianhe Road, Tianhe, Guangzhou, People's Republic of China, Tel +86 18922102608, Email Objective: To investigate the relationship and predictive value of first-trimester pregnancy-associated plasma protein A (PAPP-A), maternal factors, and biochemical parameters with gestational diabetes mellitus (GDM) in southern China mothers. Methods: This study recruited 4872 pregnant women. PAPP-A, the free beta subunit of human chorionic gonadotropin (free β-HCG), fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TG), and high- and low-density lipoproteins (HDL, LDL) were measured at 11– 13 + weeks of gestation. GDM was diagnosed based on a 75 g oral glucose tolerance test at 24– 28 weeks of gestation. We performed stepwise logistic regression analysis to determine the odds ratio (OR) and the 95% confidence interval (CI) of GDM. We used Receiver Operating Characteristic (ROC) curves with the area under the curve (AUC) to evaluate the predictive value of PAPP-A, maternal factors, and biochemical markers. The significance of the differences between the AUC values was assessed using the DeLong test. Results: GDM was diagnosed in 750 (15.39%) women. Independent factors for GDM were age, pre-gestational BMI, GWG before a diagnosis of GDM, previous history of GDM, family history of diabetes, FPG, TG, LDL, PAPP-A, and TC. The AUC of PAPP-A was 0.56 (95% CI 0.53– 0.58). The AUC of a model based on combined maternal factors, biochemical markers, and PAPP-A was 0.70 (95% CI 0.68– 0.72). Differences in AUC values between PAPP-A alone and the model based on combined maternal factors, biochemical markers, and PAPP-A were statistically significant (Z= 9.983, P< 0.001). Conclusion: A Low serum PAPP-A level in the first trimester is an independent risk factor for developing GDM later in pregnancy. However, it is not a good independent predictor although the predictive value of a low serum PAPP-A level increases when combined with maternal factors and biochemical markers. Keywords: gestational diabetes mellitus, pregnancy-associated plasma protein-A, maternal factors, biochemical markers, predictive value Gestational diabetes mellitus (GDM) is defined as the development of carbohydrate intolerance during pregnancy and is one of the most common medical complications of pregnancy. 1,2 The prevalence of GDM is increasing worldwide as obesity and lifestyles change along with delayed childbearing age. 3–5 The adverse effects of GDM on the mother and fetus include polyhydramnios, infection, postpartum hemorrhage, abortion, preterm birth, macrosomia, fetal distress, stillbirth, cesarean deliveries, and hypertensive disorders of pregnancy. 1,2 Neonatal morbidities associated with GDM include birth injury, respiratory distress syndrome, hypoglycemia, polycythemia, or hyperbilirubinemia. 1,2 Women with a history of GDM are at increased risk of future diabetes, predominantly type 2. 2 GDM has been implicated in the increased incidence of diabetes and cardiovascular disease in general 6 and type 2 diabetes in offspring. 7 Risk factors associated with GDM include advanced maternal age, obesity, multiparity, history of GDM, family history of diabetes, high-risk race or ethnicity, and others. 2,8 Screening in early pregnancy for GDM is suggested in women with high-risk factors. 2 However, the best screening test for early detection of GDM is unclear, and the cut-off point for detection before 24 weeks is also unclear. 8–10 To date, universal screening and diagnosis of GDM are performed mainly between 24 and 28 weeks of gestation, delaying the diagnosis or often making the diagnosis after complications occur. 8–10 Even though low- or middle-income countries account for 80% of the global diabetes burden, most pregnant women are not screened for GDM. 1 Although earlier prediction could reduce the incidence of adverse pregnancy outcomes, 8–11 there are no effective and convenient predictors of GDM in the first trimester. Li et al previously reported that the FPG level in the first trimester is related to the development of GDM in the middle of the gestational period. 12 Many studies have shown that maternal dyslipidemia is frequently associated with GDM. 13 However, there is no consensus on the relationship between each parameter -Abstract Truncated-

Investigation Into the Predictive Potential of Three-Dimensional Ultrasonographic Placental Volume and Vascular Indices in Gestational Diabetes Mellitus

Clinical value of S/D ratio of umbilical arteries and Z-scores of multiple ultrasound parameters in evaluating fetal growth restriction in pregnant women with gestational diabetes mellitus

Clinical significance of ultrasonic umbilical artery flow analysis in pregnancy with gestational diabetes mellitus

Comparison of placental three-dimensional power Doppler indices and volume in the first and the second trimesters of pregnancy complicated by gestational diabetes mellitus

Ultrasonographic placental parameters at 11–13+6 weeks' gestation in the prediction of complications in pregnancy after assisted reproductive technology

Maternal vascular indices and hemodynamic parameters at 36 weeks' gestation in gestational and pre‐existing diabetes mellitus

A Prediction Model of Gestational Diabetes Mellitus Based on OGTT in Early Pregnancy: A Prospective Cohort Study

Early Prediction of High Risk Gestational Diabetes Mellitus <i>via</i> Machine Learning Models

Gestational Diabetes Mellitus: Predictive Value of Fetal Growth Measurements by Ultrasonography at 22–24 Weeks: A Retrospective Cohort Study of Medical Records

Early Prediction of Gestational Diabetes Mellitus in the Chinese Population Via Advanced Machine Learning

Study on the Relationship and Predictive Value of First-Trimester Pregnancy-Associated Plasma Protein-A, Maternal Factors, and Biochemical Parameters in Gestational Diabetes Mellitus: A Large Case-Control Study in Southern China Mothers

Application Value of Predictive Model Based on Maternal Coagulation Function and Glycolipid Metabolism Indicators in Early Diagnosis of Gestational Diabetes Mellitus

Use of placental vascularization indices and uterine artery peak systolic velocity in early detection of pregnancies complicated by gestational diabetes, chronic or gestational hypertension, and preeclampsia at risk

Application Value of Two‐Dimensional Ultrasound Combined With Three‐Dimensional Power Doppler in the Prediction of Macrosomia in Early Pregnancy

Associations between first-trimester screening biomarkers and maternal characteristics with gestational diabetes mellitus in Chinese women

Visceral Adipose Tissue Depth as a Novel Predictor for Gestational Diabetes Mellitus: A Comprehensive Meta-Analysis and Systematic Review

A mid-pregnancy risk prediction model for gestational diabetes mellitus based on the maternal status in combination with ultrasound and serological findings

Value of 3D Ultrasonographic Assessment of Placental Volume and Perfusion Indices in The First Trimester As Predictors to The Occurrence of Preeclampsia

Ultrasonographic diagnosis of fetal hemodynamic parameters in pregnant women with diabetes mellitus in the third trimester of pregnancy

Placental and Plasma Early Predictive Biomarkers for Gestational Diabetes Mellitus.

Study on the correlation and predictive value of serum pregnancy-associated plasma protein A, triglyceride and serum 25-hydroxyvitamin D levels with gestational diabetes mellitus.